TrialEndocrinology and metabolism (Seoul, Korea)2025

Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction.

Ji Eun Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.